rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer1 and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant ...

rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant ...

rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant ...

Machine learning tools can improve personalised prognostication of aggressive skin cancers such as Merkel cell carcinoma, a ...

National Comprehensive Cancer Network® (NCCN®) Guidelines for colon and rectal cancer were updated to include ctDNA as a prognostic marker and high risk factor for recurrence NCCN guideline for merkel ...

today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for colon ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to ...